SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-271319
Filing Date
2019-10-22
Accepted
2019-10-22 09:03:46
Documents
17
Period of Report
2019-10-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d822414d8k.htm   iXBRL 8-K 65049
2 EX-3.1 d822414dex31.htm EX-3.1 8715
3 EX-3.2 d822414dex32.htm EX-3.2 41249
4 EX-4.3 d822414dex43.htm EX-4.3 25574
5 EX-10.1 d822414dex101.htm EX-10.1 34213
6 EX-10.2 d822414dex102.htm EX-10.2 135587
  Complete submission text file 0001193125-19-271319.txt   506171

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA aldr-20191018.xsd EX-101.SCH 3071
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldr-20191018_lab.xml EX-101.LAB 18126
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldr-20191018_pre.xml EX-101.PRE 11406
13 EXTRACTED XBRL INSTANCE DOCUMENT d822414d8k_htm.xml XML 3554
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Filer) CIK: 0001423824 (see all company filings)

IRS No.: 900134860 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36431 | Film No.: 191160661
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences